Rhythm Pharmaceuticals
RYTM
RYTM
105 hedge funds and large institutions have $905M invested in Rhythm Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
73% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 26
92% less call options, than puts
Call options by funds: $68K | Put options by funds: $800K
Holders
105
Holding in Top 10
1
Calls
$68K
Puts
$800K
Top Buyers
| 1 | +$8.01M | |
| 2 | +$7.51M | |
| 3 | +$6.77M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.5M |
| 5 |
BlackRock
New York
|
+$3.73M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$5.14M | |
| 3 | -$4.65M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$3.6M |